Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,013
Closed -$240K 2276
2025
Q3
$240K Buy
+8,013
New +$267K ﹤0.01% 1597
2024
Q1
Sell
-6,392
Closed -$232K 2280
2023
Q4
$232K Sell
6,392
-608
-9% -$19.9K 0.01% 1481
2023
Q3
$225K Sell
7,000
-5,403
-44% -$184K 0.01% 1455
2023
Q2
$388K Sell
12,403
-23,478
-65% -$536K 0.01% 1156
2023
Q1
$817K Buy
+35,881
New +$924K 0.03% 683

Other funds holding SRDX

Jump Financial's SRDX Position: Q4 2025 in Review

Jump Financial sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 8,013 shares — an estimated $240K sold.

Jump Financial first reported a position in SRDX in Q1 2023 and held it in 5 quarters. The position peaked at $817K in Q1 2023. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Jump Financial reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Jump Financial sold 8,013 Surmodics shares in Q4 2025, an estimated $240K.
  • Jump Financial first reported a position in Surmodics in Q1 2023 and held it in 5 quarters.
  • Jump Financial's Surmodics position peaked at $817K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Jump Financial's 13F filing for Q4 2025, filed 17 Feb 2026.